Viz.ai Partners With Hyperfine to Enable Bedside MRI in Stroke Treatment

July 26, 2022—Viz.ai, developer of an artificial intelligence (AI)–powered disease detection and intelligent care coordination platform, announced it is partnering with Hyperfine, Inc., creator of Swoop, an FDA-cleared point-of-care MRI device.

According to Viz.ai, the initiative will bring MRI to the patient’s bedside and deliver valuable insights to the clinician for timely decision-making.

Viz.ai's intelligent software is intended to reduce time to treatment, improve access to care, and increase the speed of medical innovation. The company’s flagship product, Viz LVO, leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat.

Hyperfine’s Swoop MRI system provides neuroimaging at the point of care, expanding patient access to MRI by bringing imaging to the bedside. The Swoop system allows physicians to make quick and informed clinical decisions for patients, eliminating hours of wait and transport time, and reducing the potential for adverse events associated with transporting critically ill patients.

Viz.ai stated that this partnership and the subsequent implementation in neuro intensive care units (ICUs) provides the potential to further decrease the time from admission to treatment by expediting clinician access to MRI imaging and increasing access to time-critical diagnostics in the acute and post-acute care phase.

Shahid M. Nimjee, MD, who Associate Professor of Neurosurgery, Surgical Director of the Comprehensive Stroke Center, The Ohio State University Medical Center in Columbus, Ohio, commented in the company's press release, “The partnership between Hyperfine and Viz.ai will help us integrate two breakthrough technologies that already enable us to better assess patients in a time-critical fashion and make timely decisions that will ultimately save more lives and improve outcomes. By combining these two proven technologies, we hope to further expedite care, when every second matters and transportation presents additional risk.”

Also, discussing the partnership in the press release, Jayme Strauss, chief clinical officer at Viz.ai, stated, “Partnering with Hyperfine to enhance the clinical workflow and expedite the clinical team’s access to imaging has the potential to result in better patient outcomes where time is critical in the emergency room and ICU. With this partnership, we will be able to combine Viz’s intelligent care coordination platform and leading image viewer with the Hyperfine Swoop portable MR imaging system.”

Scott Huennekens, executive chairperson of the board of Hyperfine, added, “This new partnership between Viz.ai and Hyperfine has the potential to enable health care providers to reduce neuroimaging wait times, streamline their clinical workflow coordination, and improve patient care from door to discharge.”